Articles

1. Foo L.LE, Logeshwari M.N, Czarny B, Ng K.W  Development of Keratin-based Fibers Fabricated by Interfacial Polyelectrolyte Complexation for Suture Applications.(2024) Biomaterials.READ
2. Thirunavukarasu AJ, Han E, Nedumaran A.M., Yusoff NZ, Liu YC, Valencia Foo V, Czarny B,  Riau AK, Mehta JS. Electron beam-irradiated donor cornea for on-demand lenticule implantation to treat corneal diseases and refractive error (2023) Acta Biomaterialia.READ
3. Lim PQ, Parikh A.N., Venkatraman S, and Czarny B.. (2023) Controlling the morphology of poly(ethylene glycol)-b-poly(lactide) (PEG-PLA) self-assemblies in solution: Interplay of homopolymer additive and kinetic traps, Research Square preprint READ
4. Liew. MW.J, Wong YS, Parikh A.N., Venkatraman S, Cao Y and Czarny B.. (2023) Cell-mimicking polyethylene glycol-diacrylate based nanolipogel for encapsulation and delivery of hydrophilic biomolecule. Frontiers in Bioengineering and Biotechnology READ.
5. Ravishankar S., Nedumaran A.M., Gautam A., Ng K.W., Czarny B., Sierin Lim S. (2023).  Protein nanoparticle cellular fate and responses in murine macrophages. NPG Asia Materials, 15(1):1 READ
6. Neupane YR, Alkaff S.A, Handral HK, Venkatesan G, Huang C, Chng WH, Wang JW,  Sriram G, Lu WF, Ali Y, Czarny B. and Pastorin G (2022). Cell-derived nanovesicles from mesenchymal stem cells as extracellular vesicle-mimetics in wound healing. Acta Pharmaceutica Sinica READ
7. Lian M.Q, Chng W.H, Liang J.S.K, Yeo H.Q, Lee C.K, Czarny B, Pastorin G (2022). Plant-Derived Extracellular Vesicles: Recent Advancements and Challenges of a Novel Therapeutic Strategy. Journal of extracellular vesicles, 11(12):e12283.READ
8. Su X., Wu X., Chen S., Nedumaran A.M., Stephen M., Hou K., Czarny B., and Leong W.L. (2022). A Highly Conducting Polymer for Self-Healable, Printable, and Stretchable Organic Electrochemical Transistor Arrays and Near Hysteresis-Free Soft Tactile Sensors. Advanced Materials, 34(19):e2200682.READ
9. Neupane Y.R., Huang C., Wang X., Chng W.H., Venkatesan G., Zharkova O., Wacker M.G., Czarny B., Storm G., Wang J.-W., and Pastorin G. (2021). Lyophilization Preserves the Intrinsic Cardioprotective Activity of Bioinspired Cell-Derived Nanovesicles. Pharmaceutics, 13(7), 1052. READ
10. Ou Y.-H., Shui Z., Wang J.W., Czarny B., and Pastorin G. (2021). Cell-Derived Nanovesicles As Exosonne-Mimetics For Drug Delivery Purposes: Uses & Recommendations. In: Narayanan K. (eds) Bio-Carrier Vectors: Methods and Protocols, vol 2211. New York: Springer. ISBN: 978-1-0716-0942-2. pp. 147-170. READ
11. Ou Y.-H., Liang J., Czarny B., Wacker M.G., Yu V., Wang J.-W., and Pastorin G. (2021). Extracellular Vesicle (EV) biohybrid systems for cancer therapy: Recent advances and future perspectives. Seminars in Cancer Biology. READ
12. Huang C., Neupane Y.R., Lim X.C., Shekhani R., Czarny B., Wacker M.G., Pastorin G., and Wang J.-W. (2020). Extracellular vesicles in cardiovascular disease. In: Makowski G.S. (eds) Advances in Clinical Chemistry, Elsevier, 2020. READ
13. Vidaillac C., Yong C.F.L., Aschtgen M.-S., Qu J., Yang S., Xu G., Seng Z.J., Brown A.C., Ali M.K., Jaggi T.K., Sankaran J., Foo Y.H., Righetti F., Nedumaran A.M., Mac Aogáin M., Roizman D., Richard J.-A., Rogers T.R., Toyofuku M., Luo D., Loh E., Wohland T., Czarny B., Horvat J.C., Hansbro P.M., Yang L., Li L., Normark S., Henriques-Normark B., and Chotirmall S.H. (2020). Sex Steroids Induce Membrane Stress Responses and Virulence Properties in Pseudomonas aeruginosa. mBio, 11(5), e01774-20. READ
14. Ou Y.-H., Zou S., Goh W.J., Chong S.Y., Venkatesan G., Wacker M.G., Storm G., Wang J.-W., Czarny B., Pastorin G., and Woon C.Y. (2020).Micro Cell Vesicle Technology (mCVT): A Novel Hybrid System of Gene Delivery for Hard-To-Transfect (HTT) Cells. Nanoscale, 12, 18022-18030. READ
15. Darwitan A., Wong Y.S., Nguyen L.T.H.,Czarny B., Vincent A., Nedumaran A.M., Tan Y.F., Muktabar A., Tang J.K., Ng K.W. and Venkatraman S.S. (2020). Liposomal Nanotherapy for Treatment of Atherosclerosis. Advanced Healthcare Materials, 9(14), 2000465. READ
16. Lim SWZ, Wong YS, Czarny B, Venkatraman SS. Microfluidic-directed self-assembly of liposomes: Role of interdigitation. Journal of Colloid and Interface Science, Jun 2020, IP 6.3. READ
17. Darwitan A, Tan YF, Wong YS, Nedumaran AM, Czarny B, Venkatraman SS. Targeting efficiency of nanoliposomes on atherosclerotic foam cells: Polyethylene glycol-to-ligand ratio effects Expert Opinion on Drug Delivery Jun 2020, IP 3.5. READ
18. SA Alkaff, K Radhakrishnan, AM Nedumaran, P Liao, B Czarny. Nanocarriers for Stroke Therapy: Advances and Obstacles in Translating Animal Studies. International Journal of Nanomedicine. Jan 2020, IP 5.0. READ
19. Saw S, Aiken A, Fang H, McKee TD, Bregant S, Sanchez O, Chen Y, Weiss A, Dickson BC, Czarny B, Sinha A, Fosang A, Dive V, Waterhouse PD, Kislinger T, Khokha R. Metalloprotease inhibitor TIMP proteins control FGF-2 bioavailability and regulate skeletal growth..J Cell Biol. 2019 Aug, IP 8.9. READ
20. Babak MV, Zhi Y, Czarny B, Toh TB, Hooi L, Chow EK, Ang WH, Gibson D and Pastorin G. Dual-targeting Dual-action Platinum(IV) Platform for Enhanced Anticancer Activity and Reduced Nephrotoxicity Angewandte Chemie, April 2019, IP 12.3. READ
21. Wong YS, Czarny B, Venkatramana SS. Precision nanomedicine in atherosclerosis therapy: how far are we from reality? Precision Nanomedicine, Jan 2019. READ
22. Wong CW*, Czarny B*, Metselaar J, Ho C, Ng SR, Veluchamy AB, Storm G, and Wong T Evaluation of subconjunctival liposomal steroids for the treatment of experimental uveitis Scientific report April 2018, IP 4.1. READ
23. Goh WJ, Zou S, Czarny B, Pastorin G. nCVTs: A Hybrid Smart Tumour Targeting Platform, Mar 2018, IP 7.2. READ
24. Obuobi S, Voo ZX, Low MW, Czarny B, Selvarajan V, Ibrahim NL, Yang YY and Ee PLR. Phenylboronic Acid Functionalized Polycarbonate Hydrogels for Controlled Release of Polymyxin B in Pseudomonas Aeruginosa Infected Burn Wounds, Advanced Healthcare Materials. Mar 2018, IP 6.3. READ
25. Goh WJ, Zou S, Lee CK, Wang JW, Czarny B, Pastorin G. EXOPLEXs: Chimeric Drug Delivery Platform from the fusion of Cell Derived Nanovesicles and Liposomes biomacromolecules. Nov 2017, IP 5.7. READ
26. Goh WJ, Ong WY, Torta F, Schiffelers RM, Storm G, Pastorin G *, Czarny B*. Bioinspired Cell-Derived Nanovesicles versus Exosomes as Drug Delivery Systems: A Cost-Effective Alternative, Scientific report. Oct 2017, IP 4.1. READ
27. Nayak TR, Hao W, Pant A, Zheng M, Junginger H, Goh WJ, Lee CK, Zou S, Alonso S, Czarny B, Storm G, Sow CH, Lee C and Pastorin G. ZnO nano-rod devices for transdermal delivery and immunization, Nanomaterials, June 2017, IP 3.5. READ
28. Goh WJ, Lee CK, Zou S, Woon E, Czarny B, Pastorin G. Doxorubicin loaded Cell Derived Nanovesicles: An Alternative Targeted Approach for Anti-Tumor Therapy, International Journal of Nanomedicine, February 2017, IP 4.4. READ
29. Czarny BM, Allijn IE, Wang X, Chong SY, Weiler M, da Silva AE, Metselaar JM, Lam CS, Pastorin G, de Kleijn DP, Storm G, Wang JW, Schiffelers RM. Liposome encapsulated berberine treatment attenuates cardiac dysfunction after myocardial infarction. J Control Release. January 2017, IP 7.9. READ
30. Rouanet-Mehouas C, Czarny B, Beau F, Cassar-Lajeunesse E, Stura EA, Dive V, Devel L. Zinc-Metalloproteinase Inhibitors: Evaluation of the Complex Role Played by the Zinc-Binding Group on Potency and Selectivity. J Med Chem. 2016, IP 5.4. READ
31. Audisio, D; Czarny, B; Georgin, D; Berthon, F; Plastow, G; Pinault, M; Patriarche, G; Thuleau, A; L’Hermite, MM; Dive, V; Tarana, F. Combining efficient C-14-radiolabeling and radioimaging techniques of manufactured nanoparticles for toxicological studies J Labelled Comp Radiopharm. 2016, IP 1.4. READ
32. Li J, Yoong L, Goh WJ, Czarny B, Yang Z, Poddar K, Dykas M, Patra A, Venkatesan T, Lee C and Pastorin G; In vitro Controlled Release of Cisplatin from Gold-Carbon Nanobottles via Cleavable Linkages, International Journal of Nanomedicine, 2015, IP 4.4. READ
33. Pant K, Gröger D, Bergmann R, Pietzsch J, Steinbach J, Graham B, Spiccia L, Berthon F, Czarny B, Devel L, Dive V, Stephan H, Haag R. Synthesis and Biodistribution Studies of 3H- and 64Cu-labeled Dendritic Polyglycerol and Dendritic polyglycerol Sulfate. Bioconjugate Chem., April 19, 2015, IP 4.5. READ
34. Czarny B., Georgin D., Berthon F., Plastow G., Pinault M., Patriarche G., Thuleau A., Mayne-L’Hermite M., Taran F. and Dive V., Carbon nanotube translocation to distant organs after pulmonary exposition: insights from in situ ¹⁴C radiolabelling and tissue radioimaging. ACS Nano, 2014 May 28, IP 13.7. READ
35. Meides A ., Gutschalk CM., Devel L., Beau F., Czarny B., Hensler S., Neugebauer J., Dive V., Angel P., Mueller MM., Effects of selective MMP-13 inhibition in Squamous Cell Carcinoma depend on estrogen. Int J Cancer, 2014 Mar 27, IP 7.4. READ
36. Tranchant I.,Vera L., Czarny B., Amoura M., Cassar-Lajeunesse E., Beau F., Stura E.A., and Dive V., Halogen Bonding Controls Selectivity of FRET Substrate Probes for MMP-9. Chemistry and biology, 2014 Mar 20, IP 7.6. READ
37. Masuyer G., Akif M., Czarny B., Beau F., Schwager S., Sturrock E.D., Isaac R.E., Dive V. and Acharya R., Crystal structures of highly specific phosphinic tripeptide enantiomers in complex with the angiotensin-I converting enzyme. FEBS, 2014 Feb, IP 4.5. READ
38. Georgin D., Czarny B., Ferrie M., Pinault M., Mayne-L’Hermite M., Carriere M., Dive V. and Taran F., On the trail of in vivo carbon nanotubes, 2013 Biofutur 347: p. 25-28 IP 0.1. READ
39. Czarny B., Georgin D., Pinault M. and Dive V. Carbon nanotubes passes pulmonary barrier 2013 Biofutur 358: p. 52-53, IP 0.1. READ
40. Antoni C., Vera L., Devel L., Catalani M.P., Czarny B., Cassar-Lajeunesse E., Nuti E., Rossello A., Dive V., and Stura E.A., Crystallization of bi-functional ligand protein complexes. J Struct Biol, 2013. 182(3): p. 246-54. IP 3.4. READ
41. Vera L., Antoni C., Devel L., Czarny B., Cassar-Lajeunesse E., Rossello A., Dive V., and Stura E.A., Screening Using Polymorphs for the Crystallization of Protein−2 Ligand Complexes Crystal Growth & Design, 2013. 13(5):  1878-1888, IP 4.0. READ
42. Czarny B., Stura E.A., Devel L., Vera L., Cassar-Lajeunesse E., Beau F., Calderone V., Fragai M., Luchinat C., and Dive V., Molecular determinants of a selective matrix metalloprotease-12 inhibitor: insights from crystallography and thermodynamic studies. Journal of Medicinal Chemistry, 2013. 56(3): p. 1149-59. IP 6.3. READ
43. Nury C., Bregant S., Czarny B., Berthon F., Cassar-Lajeunesse E., and Dive V., Detection of Endogenous Matrix Metalloprotease-12 Active Form with a Novel Broad Spectrum Activity-based Probe. Journal of biological chemistry, 2013. 288(8): p. 5636-44. IP 4.0. READ
44. Nury C., Czarny B., Cassar-Lajeunesse E., Georgiadis D., Bregant S., and Dive V., A Pan Photoaffinity Probe for Detecting Active Forms of Matrix Metalloproteinases. ChemBioChem, 2013. 14(1): p. 107-114. IP 2.8. READ
45. Larue C., Pinault M., Czarny B., Georgin D., Jaillard D., Bendiab N., Mayne-L’Hermite M., Taran F., Dive V., and Carrière M., Quantitative evaluation of multi-walled carbon nanotube uptake in wheat and rapeseed. Journal of Hazardous Materials, 2012. 227–228(0): p. 155-163. IP 6.4. READ
46. Devel L., Beau F., Amoura M., Vera L., Cassar-Lajeunesse E., Garcia S., Czarny B., Stura E.A., and Dive V., Simple Pseudo-dipeptides with a P2′ Glutamate: a novel inhibitor family of matrix metalloproteases and other metzincins. Journal of biological chemistry, 2012. 287(32): p. 26647-56. IP 4.0. READ
47. Martinage O., Le Clainche L., Czarny B., and Dugave C., Synthesis and biological evaluation of a new triazole-oxotechnetium complex. Organic & Biomolecular Chemistry, 2012. 10(32): p. 6484-6490. IP 3.4. READ
48. Garofalakis A., Dubois A., Thézé B., Czarny B., Tavitian B., and Ducongé F., Fusion of [[(18)F]FDG PET with Fluorescence Diffuse Optical Tomography to Improve Validation of Probes and Tumor Imaging. Molecular Imaging and Biology, 2012: p. 1-10. IP 3.4. READ
49. Vera L., Czarny B., Georgiadis D., Dive V., and Stura E.A., Practical Use of Glycerol in Protein Crystallization. Crystal Growth & Design, 2011. 11(7): p. 2755-2762 IP 4.0. READ
50. Akif M., Schwager S.L., Anthony C.S., Czarny B., Beau F., Dive V., Sturrock E.D., and Acharya K.R., Novel mechanism of inhibition of human angiotensin-I-converting enzyme (ACE) by a highly specific phosphinic tripeptide. Biochemical Journal, 2011. 436(1): p. 53-59. IP 3.9. READ
51. Aufort M., Gonera M., Lelait M.-A., Czarny B., Le Clainche L., Thaï R., Landra A., Ruinart de Brimont M., and Dugave C., Synthesis, in vitro screening and in vivo evaluation of cyclic RGD analogs cyclized through oxorhenium and oxotechnetium coordination. European Journal of Medicinal Chemistry, 2011. 46(5): p. 1779-1788. IP 4.8. READ
52. Aufort M., Gonera M., Le Gal J., Czarny B., Le Clainche L., Thai R., and Dugave C., Oxorhenium-Mediated Assembly of Noncyclic Selective Integrin Antagonists: A Combinatorial Approach. ChemBioChem, 2011. 12(4): p. 583-592. IP 2.8. READ
53. Johnson J.L., Devel L., Czarny B., George S.J., Jackson C.L., Rogakos V., Beau F., Yiotakis A., Newby A.C., and Dive V., A Selective Matrix Metalloproteinase-12 Inhibitor Retards Atherosclerotic Plaque Development in Apolipoprotein E-Knockout Mice. Arteriosclerosis Thrombosis and Vascular Biology, 2011. 31(3): p. 528-U127. IP 6.1. READ
54. Devel L., Garcia S., Czarny B., Beau F., Lajeunesse E., Vera L., Georgiadis D., Stura E., and Dive V., Insights from Selective Non-phosphinic Inhibitors of MMP-12 Tailored to Fit with an S-1 ‘ Loop Canonical Conformation. Journal of Biological Chemistry, 2010. 285(46): p. 35900-35909. IP 4.0. READ
55. Devel L., Czarny B., Beau F., Georgiadis D., Stura E., and Dive V., Third generation of matrix metalloprotease inhibitors: Gain in selectivity by targeting the depth of the S ‘(1) cavity. Biochimie, 2010. 92(11): p. 1501-1508. IP 3.2. READ
56. Pallafacchina G., François S., Regnault B., Czarny B., Dive V., Cumano A., Montarras D., and Buckingham M., An adult tissue-specific stem cell in its niche: A gene profiling analysis of in vivo quiescent and activated muscle satellite cells. Stem Cell Research, 2010. 4(2): p. 77-91. IP 1.8. READ
57. Georgin D., Czarny B., Botquin M., Mayne-L’Hermite M., Pinault M., Bouchet-Fabre B., Carriere M., Poncy J.-L., Chau Q., Maximilien R., Dive V., and Taran F., Preparation of 14C-Labeled Multiwalled Carbon Nanotubes for Biodistribution Investigations. Journal of the American Chemical Society, 2009. 131(41): p. 14658-14659. IP 14.4. READ
58. Dabert-Gay A.S., Czarny B., Lajeunesse E., Thai R., Nagase H., and Dive V., Covalent Modification of Matrix Metalloproteinases by a Photoaffinity Probe: Influence of Nucleophilicity and Flexibility of the Residue in Position 241. Bioconjugate Chemistry, 2009. 20(2): p. 367-375. IP 4.4. READ
59. Bregant S., Huillet C., Devel L., Dabert-Gay A.-S., Beau F., Thai R., Czarny B., Yiotakis A., and Dive V., Detection of Matrix Metalloproteinase Active Forms in Complex Proteomes: Evaluation of Affinity versus Photoaffinity Capture. Journal of Proteome Research, 2009. 8(5): p. 2484-2494. IP 4.0. READ
60. Dabert-Gay A.S., Czarny B., Devel L., Beau F., Lajeunesse E., Bregant S., Thai R., Yiotakis A., and Dive V., Molecular Determinants of Matrix Metalloproteinase-12 Covalent Modification by a Photoaffinity probe insights into activity- based probe development and conformational variability of matrix metalloproteinases. Journal of Biological Chemistry, 2008. 283(45): p. 31058-31067. IP 4.0. READ
61. Georgiadis D., Beau F., Czarny B., Cotton J., Yiotakis A., and Dive V., Roles of the Two Active Sites of Somatic Angiotensin-Converting Enzyme in the Cleavage of Angiotensin I and Bradykinin. Circulation Research, 2003. 93(2): p. 148-154. IP 15.2. READ

Book chapter’s

1. Cell-Derived Nanovesicles As Exosome-Mimetics For Drug Delivery Purposes: Uses & Recommendations, Ou YH, Shui Z, Wang JW, Czarny B, Pastorin G, “Bio-Carrier Vectors” in Methods in Molecular Biology series by Springer Nature, 2020 DOI:10.1007/978-1-0716-0943-9
2. Extracellular vesicles in cardiovascular diseases, Huang C, Neupane YR, Lim CX, Shekhani R, Czarny B, Wacker MG, Pastorin G, Wang JW, Advances in Clinical Chemistry, 2020, DOI: 10.1016/bs.acc.2020.08.006

Patents

• Patent Number: US 07541157 / WO2011/023864, 2011, CEA, Pseudo-dipeptides as MMP inhibitors, DEVEL Laurent ; DIVE Vincent ; BEAU Fabrice ; CZARNY Bertrand.

• Patent Number: US 08691753 / W0206698, 2004, CEA, Method of screening groups of radioactive molecules and applications thereof . DIVE Vincent; BEAU Fabrice; CZARNY Bertrand; COTTON Joel; MENEZ André; STOCKLIN Reto.

• • Patent application: 2017/3082562576U / C201703740Y, 2017, Enceladus Pharmaceuticals B.V. Universiteit Utrecht Holding B.V. Singapore Eye Research Institute. Liposomal corticosteroids for topical injection in inflamed lesions or areas.